Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation

Pain

Volumn 72, Issue 3, 1997, Pages 333-346

  Coda, Barbara A ^a,b   O'Sullivan, Barbara ^a   Donaldson, Gary ^a   Bohl, Sharol ^a   Chapman, C Richard ^a,b   Shen, Danny D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hydromorphone; Morphine; Oral mucositis pain; Patient controlled analgesia; Side effects; Sufentanil

Indexed keywords

HYDROMORPHONE; MORPHINE SULFATE; OPIATE; SUFENTANIL;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MUCOSA INFLAMMATION; NAUSEA; PAIN; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE;

ADOLESCENT; ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROMORPHONE; MALE; MIDDLE AGED; MORPHINE; MOUTH MUCOSA; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; STOMATITIS; SUFENTANIL;

EID: 0030758918     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00059-6     Document Type: Article

References (46)

1. Abbott, F.V. and Palmour, R.M., Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats, Life Sci., 43 (1988) 1685-1695.
2. American Pain Society, Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 3rd edn., American Pain Society, Skokie, IL, 1992.
3. Ausems, M.E., Hug, C.C., Stanski, D.R. and Burm, A.G., Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery, Anesthesiology, 65 (1986) 362-373.
4. Baumann, T.J., Batenhorst, R.L., Graves, D.A., Foster, T.S. and Bennett, R.L., Patient-controlled analgesia in the terminally ill cancer patient, Drug Intell. Clin. Pharm., 20 (1986) 297-330.
5. Bennett, R., Batenhorst, R., Graves, D. et al., Morphine titration in post-operative laparotomy patients using patient-controlled analgesia, Curr. Ther. Res., 32 (1982a) 45-52.
6. Bennett, R.L., Batenhorst, R.L., Bivins, B.A., Bell, R.M., Graves, D.A., Foster, T.S., Wright, B.D. and Griffen, W.O., Patient-controlled analgesia: a new concept of postoperative pain relief, Ann. Surg., 195 (1982b) 700-705.
7. Bollish, S.J., Collins, C.L., Kirking, D.M. and Bartlett, R.H., Efficacy of patient-controlled versus conventional analgesia for postoperative pain relief, Clin. Pharm., 4 (1982) 48-52.
8. Cohen, J., Statistical Power Analysis for Behavioral Sciences, 2nd edn., Lawrence Erlbaum, Hillsdale, NJ, 1988.
9. Collins, J.J., Geake, J., Grier, H.E., Houck, C.S., Thaler, H.T., Weinstein, H.J., Twum-Danso, N.Y. and Berde, C.B., Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone, J. Pediatr., 129 (1996) 722-728.
10. Donaldson, G.W., Statistical power in pain research, Am. Pain Soc. Bull., 3 (1993) 11-13.
11. Dunbar, P.J., Chapman, C.R., Buckley, F.P. and Gavrin, R., Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA, Pain, 68 (1996) 265-270.
12. Egan, K.J. and Ready, L.B., Patient satisfaction with intravenous PCA vs. epidural morphine, Can. Anaesth. Soc. J., 41 (1994) 6-11.
13. Evans, J.M., Rosen, M., McCarthy, J. and Hogg, M.I.J., Apparatus for patient-controlled administration of intravenous narcotic during labor, Lancet, I (1976) 17.
14. Flacke, J.W., Bloor, B.C., Kripke, B.J., Flacke, W.E., Warneck, C.M., Van Etton, A.P., Wong, D.H. and Katz, R.L., Comparison of morphine, meperidine, fentanyl, and sufentanil in balanced anesthesia: a double-blind study, Anesth. Analg., 64 (1985) 897-910.
15. Forest, W.H., Smethurst, P.W.R. and Kienitz, M.E., Self-administration of intravenous analgesics, Anesthesiology, 33 (1970) 363-365.
16. Frances, B., Gout, R., Monsarrat, B., Cros, J. and Zajac, J.M., Further evidence that morphine-6-beta-glucuronide is a more potent opioid agonist than morphine, J. Pharmacol. Exp. Ther., 262 (1992) 25-31.
17. Hanna, M.H., Peat, S.J., Knibb, A.A. and Fung, C., Disposition of morphine-6-glucuronide and morphine in healthy volunteers, Br. J. Anaesth., 66 (1991) 103-107.
18. Hill, H.F., Chapman, C.R., Kornell, J.A., Sullivan, K.M., Saeger, L.C. and Benedetti, C., Self-administration of morphine in bone marrow transplant patients reduces drug requirement, Pain, 40 (1990) 121-129.
19. Hill, H.F., Mackie, A.M., Coda, B.A., Iverson, K. and Chapman, C.R., Patient-controlled analgesic administration - a comparison of steady-state morphine infusions with bolus doses, Cancer, 67 (1991) 873-882.
20. Hill, H.F., Coda, B.A., Mackie, A.M. and Iverson, K., Patient-controlled analgesic infusions: alfentanil versus morphine, Pain, 49 (1992) 301-310.
21. Hull, C.J. and Sibbald, A., Control of postoperative pain by interactive demand analgesia, Br. J. Anaesth., 53 (1981) 385-391.
22. Galer, B.S., Coyle, N., Pasternak, G.W. and Portenoy, R.K., Individual variability in the response to different opioids: report of five cases, Pain, 49 (1992) 87-91.
23. Jacox, A., Carr, D., Payne, R. and Al, E., Management of Cancer Pain: Clinical Practice Guideline, AHCPR Publication No. '94-0592, 1994.
24. Keeri-Szanto, M., Apparatus for demand analgesia, Can. Anaesth. Soc. J., 18 (1971) 581-582.
25. Keeri-Szanto, M. and Heaman, S., Postoperative demand analgesia, Surg. Gynecol. Obstet., 134 (1972) 647-652.
26. Lehmann, K.A., Patient-controlled intravenous analgesia for postoperative pain relief. In: M.B. Max, R.K. Portenoy and E.M. Laska (Eds.), Advances in Pain Research and Therapy, Vol. 18, Raven Press, New York, 1991, pp. 481-506.
27. Lehmann, K.A. and Zech, D., Morphine-6-glucuronide, a pharmacologically active morphine metabolite: a review of the literature, Eur. J. Pain, 14 (1993) 28-35.
28. Lehmann, K.A., Gerhard, A., Horrichs-Haermeyer, G., Grond, S. and Zeck, D., Postoperative patient-controlled analgesia with sufentanil: analgesic efficacy and minimum effective concentrations, Acta Anesth. Scand., 35 (1991) 221-226.
29. Mackie, A.M., Coda, B.C. and Hill, H.F., Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain, Pain, 46 (1991) 265-269.
30. Mather, L.E. and Owens, H., The scientific basis of patient-controlled analgesia, Anaesth. Intens. Care, 16 (1988) 427-447.
31. Osborne, R., Thompson, P., Joel, S., Duncan, T., Patel, N. and Slevin, M., The analgesic activity of morphine-6-glucuronide, Br. J. Clin. Pharmacol., 34 (1992) 130-138.
32. Paul, D., Standifer, K.M., Inturrisi, C.E. and Pasternak, G.W., Pharmacological characterization of morphine-6-beta-glucuronide, a very potent morphine metabolite, J. Pharmacol. Exp. Ther., 251 (1989) 477-483.
33. Peat, S.J., Hanna, M.H., Woodham, M., Knibb, A.A. and Ponte, J., Morphine-6-glucuronide: effects on ventilation in normal volunteers, Pain, 45 (1991) 101-104.
34. Rosow, C., Pharmacology of opioid analgesic agents. In: M.C. Rogers, J.H. Tinker, B.G. Covino and D.E. Longnecker (Eds.), Principles and Practice of Anesthesiology, Mosby Year Book, St. Louis, 1993, pp. 1155-1181.
35. SAS Institute, Inc., SAS Technical Report P-229 (6.07), Cary, NC, 1993.
36. Schubert, M.M., Williams, B.E., Lloid, M.E., Donaldson, G. and Chapko, M.K., Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation, Cancer, 69 (1992) 2469-2477.
37. Sechzer, P.H., Studies in pain with the analgesic-demand system, Anesth. Analg., 50 (1971) 1-10.
38. Shimomura, K., Kamata, O., Ueki, S., Ida, S., Oguri, K., Yoshimura, H. and Tsukamoto, H., Analgesic effect of morphine glucuronides, Tohoku J. Exp. Med., 105 (1971) 45-52.
39. Sinatra, R.S., Sevarino, F.B., Chung, J.H., Graf, G., Paige, D., Takla, V. and Silverman, D.G., Comparison of epidurally administered sufentanil, morphine, and sufentanil-morphine combination for postoperative analgesia, Anesth. Analg., 72 (1991) 522-527.
40. Smythe, M., Patient-controlled analgesia: a review, Pharmacotherapy, 12 (1992) 132-143.
41. Stain, F., Barjavel, M.J., Sandouk, P., Plotkine, M., Scherrmann, J. and Bhargava, H.N., Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-β-D-glucuronide in the rat, J. Pharmacol. Exp. Ther., 274 (1995) 852-857.
42. Tamsen, A., Hartvig, P., Fagerlund, C. and Dahlstrom, B., Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain, Clin. Pharmacokinet., 7 (1982) 164-175.
43. Thompson, P.I., Joel, S.P., John, L., Wedzicha, J.A., MacLean, M. and Slevin, M., Respiratory depression following morphine and morphine-6-glucuronide in normal subjects, Br. J. Clin. Pharmacol., 40 (1995) 145-152.
44. Tiseo, P.J., Thaler, H.T., Lapin, J., Inturrisi, C.E., Portenoy, R.K. and Foley, K.M., Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients, Pain, 61 (1995) 47-54.
45. Ved, S.A., Dubois, M., Carron, H. and Lea, D., Sufentanil and alfentanil pattern of consumption during patient-controlled analgesia - a comparison with morphine, Clin. J. Pain, 5(Suppl. 1)(1989) S63-S70.
46. Wolff, T., Samuelsson, H. and Hedner, T., Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients, Pain, 68 (1996) 209-216.